Rate My Professor Hugo Turner

Hugo Turner is an Assistant Professor in the School of Public Health within the Faculty of Medicine at Imperial College London. He is based in the Department of Infectious Disease Epidemiology and is a member of the MRC Centre for Global Infectious Disease Analysis. Turner's research focuses on health economic analyses of infectious diseases in low- and middle-income countries. He specializes in performing costings of healthcare interventions, cost-of-illness analysis, and cost-effectiveness analysis across a wide range of infectious diseases, including neglected tropical diseases such as schistosomiasis, soil-transmitted helminths, and onchocerciasis; arboviruses like dengue; as well as HCV, HPV, hospital-acquired infections, and tetanus.

Tuner completed his PhD in Infectious Disease Epidemiology and Health Economics at Imperial College London between 2010 and 2014, with a thesis on the impact and cost of ivermectin mass drug administration programmes on soil-transmitted helminthiasis in Vietnam. He also holds an MSc in Modern Epidemiology (Merit) from Imperial College London (2009-2010). His professional career includes serving as an Economist at the Oxford University Clinical Research Unit in Ho Chi Minh City, Vietnam from August 2016 to January 2020, and as Research Stream Leader for Health Economics at the London Centre for Neglected Tropical Disease Research from December 2013 to July 2016. Turner co-leads the health economics module in Imperial College London's Global Master of Public Health programme and teaches on the MSc in International Health and Tropical Medicine.

Key publications by Turner include 'An Introduction to the Main Types of Economic Evaluations Used in Infectious Disease Transmission Dynamic Modelling' (Frontiers in Public Health, 2021), 'Economic evaluations of human schistosomiasis interventions: current evidence and research needs' (Wellcome Open Research, 2020), 'An Updated Economic Assessment of Moxidectin Treatment for Onchocerciasis' (Clinical Infectious Diseases, 2024), 'Cost-effectiveness of scaling up mass drug administration for soil-transmitted helminths: an opportunity to reach the London Declaration goals' (The Lancet Infectious Diseases, 2016), and 'Reaching the London Declaration on Neglected Tropical Diseases goals: an exploration of hard-to-reach communities' (PLOS Neglected Tropical Diseases, 2014). His research contributes to evidence-based policymaking for infectious disease control programmes globally.